These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30047502)

  • 1. Angiotensin Receptor Neprilysin Inhibitor in Japanese Patients With Heart Failure and Reduced Ejection Fraction　- Baseline Characteristics and Treatment of PARALLEL-HF Trial.
    Tsutsui H; Momomura SI; Saito Y; Ito H; Yamamoto K; Ohishi T; Okino N; Kitamura T; Guo W
    Circ J; 2018 Sep; 82(10):2575-2583. PubMed ID: 30047502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sacubitril/valsartan on renal function and outcome in patients with heart failure and reduced ejection fraction: an Italian cohort study.
    Palazzuoli A; Pirrotta F; Cartocci A; Delcuratolo E; Dini FL; Correale M; Dattilo G; Masarone D; Scelsi L; Ghio S; Tocchetti CG; Mercurio V; Brunetti ND; Nodari S; Barillà F; Ambrosio G; Carluccio E
    Ther Adv Cardiovasc Dis; 2024; 18():17539447241285136. PubMed ID: 39611607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure: Post Hoc Analysis of the PARADIGM-HF and PARAGON-HF Randomized Clinical Trials.
    Lu H; Claggett BL; Packer M; Lam CSP; Swedberg K; Rouleau J; Zile MR; Lefkowitz M; Desai AS; Jhund P; McMurray JJV; Solomon SD; Vaduganathan M
    JAMA Cardiol; 2024 Nov; 9(11):1047-1052. PubMed ID: 39210725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial.
    Shaddy R; Burch M; Kantor PF; Solar-Yohay S; Garito T; Zhang S; Kocun M; Mao C; Cilliers A; Wang X; Canter C; Rossano J; Wallis G; Menteer J; Daou L; Kusa J; Tokel K; Dilber D; Xu Z; Xiao T; Halnon N; Daly KP; Bock MJ; Zuckerman W; Singh TP; Chakrabarti M; Levitas A; Senni M; Grutter G; Kim GB; Song J; Lee HD; Chen CK; Sanchez-de-Toledo J; Law Y; Wanitkun S; Cui Y; Anjos R; Mese T; Bonnet D;
    Circulation; 2024 Nov; 150(22):1756-1766. PubMed ID: 39319469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney Outcomes: Comprehensive Individual Participant-Level Analysis of 6 Randomized Clinical Trials.
    Butt JH; McMurray JJV; Claggett BL; Jhund PS; Neuen BL; McCausland FR; Desai AS; Lam CSP; Pitt B; Pfeffer MA; Packer M; Beldhuis IE; Voors AA; Zannad F; Heerspink HJL; Solomon SD; Vaduganathan M
    Circulation; 2024 Dec; 150(23):1858-1868. PubMed ID: 39217458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor-neprilysin inhibition and improved ventricular-arterial coupling in heart failure with reduced ejection fraction.
    Stegmann T; Parentin L; Schirmer SH; Lavall P; Hagendorff A; Laufs U; Lavall D
    Am J Physiol Heart Circ Physiol; 2024 Dec; 327(6):H1477-H1489. PubMed ID: 39453422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of optimisation to contemporary HFrEF medical therapy with sacubitril/valsartan (Entresto) and dapaglifloziN on left Ventricular reverse remodelling as demonstrated by cardiac magnetic resonance (CMR) Imaging: the ENVI study.
    Zheng A; Adam R; Peebles C; Harden S; Shambrook J; Abbas A; Vedwan K; Adam G; Haydock P; Cowburn P; Young C; Long J; Walkden M; Smith S; Greenwood E; Olden P; Flett A
    Open Heart; 2024 Dec; 11(2):. PubMed ID: 39622578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fraction.
    Moraña-Fernández S; Vázquez-Abuín X; Aragón-Herrera A; Anido-Varela L; García-Seara J; Otero-García Ó; Rodríguez-Penas D; Campos-Toimil M; Otero-Santiago M; Rodrigues A; Gonçalves A; Pereira Morais J; Alves IN; Sousa-Mendes C; Falcão-Pires I; González-Juanatey JR; Feijóo-Bandín S; Lago F
    Biochem Pharmacol; 2024 Dec; 230(Pt 1):116571. PubMed ID: 39424202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase 9 Inhibition Combined With Valsartan and With Sacubitril/Valsartan in Experimental Ovine Heart Failure.
    Scott NJA; Charles CJ; Prickett TCR; Frampton CM; Richards AM; Rademaker MT
    J Am Heart Assoc; 2024 Dec; 13(23):e036689. PubMed ID: 39575752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative evaluation to understand barriers and facilitators to prescribing angiotensin receptor-neprilysin inhibitors (ARNi) and sodium-glucose cotransporter inhibitors (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF).
    Pradhan AM; Lussier ME; Nguyen M; Voyce SJ; Wright EA
    J Am Pharm Assoc (2003); 2024; 64(6):102224. PubMed ID: 39209218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics, treatment and prognosis of patients with chronic heart failure according to ejection fraction. Results of an Ecuadorian registry.
    Moreno-Rondón L; Ortega-Armas ME; Coronel A; Vaca I; Guevara B; Alarcón Cedeño R; Pulla D; Díaz Heredia J; Villavicencio D; Castro-Mejía A
    Acta Cardiol; 2024 Oct; 79(8):942-952. PubMed ID: 39161326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of angiotensin-receptor neprilysin inhibitors on cardiovascular events and solute transport function in peritoneal dialysis patients: a multicenter retrospective controlled study.
    Wang Y; Zhou C; Ma X; Shi Y; Zang X; Bai S; Hu Y; Lv Z; Hong H; Wang Y; Yan D; Yang X; Yu C; Jiang D; Zhuang S; Wang Y; Liu N
    Ren Fail; 2024 Dec; 46(2):2431637. PubMed ID: 39610019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation.
    Sobhy M; Eletriby A; Ragy H; Kandil H; Saleh MA; Farag N; Guindy R; Bendary A; Nayel AME; Shawky A; Khairy A; Mortada A; Zarif B; Badran H; Khorshid H; Mahmoud K; Said K; Leon K; Abdelsabour M; Tawfik M; Abdelmegid MAF; Koriem M; Loutfi M; Wadie M; Elnoamany M; Sadaka M; Seleem M; Zahran M; Amin OA; Elkaffas S; Ayad S; Kilany WE; Ammar W; Elawady W; Elhammady W; Abdelhady Y
    Cardiol Ther; 2024 Dec; 13(4):707-736. PubMed ID: 39455534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting Race and the Benefit of RAS Blockade in Heart Failure: A Meta-Analysis of Randomized Clinical Trials.
    Shen L; Lee MMY; Jhund PS; Granger CB; Anand IS; Maggioni AP; Pfeffer MA; Solomon SD; Swedberg K; Yusuf S; McMurray JJV
    JAMA; 2024 Jun; 331(24):2094-2104. PubMed ID: 38809561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Management Strategies of Cardiologists in Heart Failure with Reduced Ejection Fraction in Türkiye.
    Kocabaş U; Özçalık E; Kıvrak T; Altın C; Türk UÖ
    Turk Kardiyol Dern Ars; 2024 Dec; 52(8):581-589. PubMed ID: 39620289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better.
    Loria F; Mone P; Rispoli A; Di Fonzo R; Masarone D; Mancusi C; Correale M; Vitullo A; Granatiero M; Mazzeo P; Mercurio V; Fiore F; Di Sarro E; Falco L; Izzo C; Campanile A; Virtuoso N; Stabile E; Bonanno S; Dattilo G; Tocchetti CG; Santulli G; Vecchione C; Ciccarelli M; Visco V
    Cardiovasc Diabetol; 2024 Nov; 23(1):423. PubMed ID: 39578847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.